PRICE T ROWE ASSOCIATES INC /MD/
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 80255
BALTIMORE, MD
Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$47,946
-$41,257 QoQ
Shares Held
111,504
0.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. HRTX ranks #294 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,946 | 111,504 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $89,203 | 111,504 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $99,629 | 76,638 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $96,563 | 76,638 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,965,070 | 2,881,677 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,610,287 | 3,004,676 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $70,653 | 46,179 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $74,615 | 37,495 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $131,232 | 37,495 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $82,883 | 29,922 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,082 | 25,931 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $21,428 | 20,804 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $65,660 | 56,604 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $82,381 | 54,557 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $120,592 | 48,237 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $194,622 | 46,119 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $88,632 | 31,768 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $190,064 | 33,228 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $273,854 | 29,995 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $570,792 | 53,395 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $785,234 | 50,595 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $930,794 | 57,421 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,492,442 | 70,498 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,064,742 | 71,845 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $928,421 | 63,115 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $726,048 | 61,844 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||